Cellular Biomedicine Group
Palo Alto
About Cellular Biomedicine Group
Cellular Biomedicine Group is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. It is the result of the acquisition, transfer, commercialization, and advancement of thirty years of research and human treatment experience in cellular medicine. Its cellular research and development is the result of collaboration among scientists and doctors from the US, England, and China.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $203.6M
- Funding stage: IPO
- Last round: Series A (Sep 2021)
- Ticker: nasdaq:CBMG
- Website: cellbiomedgroup.com
- Phone: +1 650-566-5064
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cellular-biomedicine-group-186720 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.